UniQure NV - Company Profile
Powered by 
All the data and insights you need on UniQure NV in one report.
$295
- Save hours of research time and resources with
our up-to-date UniQure NV Strategy Report
- Understand UniQure NV position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on UniQure NV’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into UniQure NV's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
David Meek
Chairman Executive BoardMr. David Meek has been the Chairman of the company since 2021. Prior to this, he served as the Chief Executive Officer and Director at Mirati Therapeutics. Before that, he served as the President & Chief Executive Officer, Director at FerGene. Previously, he served as the Chief Executive Officer and a member of the Board at Ipsen. Mr. Meek also served as the Executive Vice-President and President of the oncology division of Baxalta. Before that, he served as the Chief Commercial Officer of Endocyte.
Matthew Kapusta
Director; Chief Executive Officer Executive BoardMr. Matthew Kapusta has been the Chief Executive Officer and a Director of the company since 2016, he also serving as the Chief Financial Officer of the company since he joined in FY2015. Prior to this, he served as the Senior Vice President at AngioDynamics from FY2011 to FY2014; the Vice President, Finance at Smith & Nephew Orthopaedics; the Managing Director, Healthcare Investment Banking at Collins Stewart, and held various positions at Wells Fargo Securities, Robertson Stephens and PaineWebber.
Christian Klemt
Chief Financial Officer Senior ManagementMr. Christian Klemt has been the Chief Financial Officer of the company since 2021. Prior to this, she served as the Chief Accounting Officer of the company since August 2017. Before that, he served as the Global Controller of the company from September 2015 until August 2017. Mr. Klemt was the Regional Finance Director and Country Manager at CGG SA and also held various senior finance roles including Group Finance Manager at Basell Polyolefines N.V. (now LyondellBasell N.V.).
David Cerveny
Secretary; General Counsel; Chief Legal Officer Senior ManagementMr. David Cerveny has been the Chief Legal Officer, General Counsel and Secretary of the company since March 2018. Prior to this, he served as the Chief Legal Officer, General Counsel and Secretary at ConforMIS, Inc. from 2008 until 2018. Mr. Cerveny served as the Chief Intellectual Property Counsel at Palomar Medical Technologies, Inc and Partner at Wilmer Cutler Pickering Hale and Dorr LLP.
Walid Abi-Saab, M.D
Chief Medical Officer Senior ManagementMr. Walid Abi-Saab, M.D has been the Chief Medical Officer of the company since June 2023. Prior to this, he served as a Chief Medical Officer from 2017 to 2022 at Galapagos and Group Vice President, Global Clinical Development at Shire. Previously he served at Novartis, Abbott Laboratories, and Pfizer.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer